Envoy Medical (NASDAQ:COCH – Free Report) had its price target boosted by Ascendiant Capital Markets from $8.50 to $8.75 in a research report released on Tuesday, Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.
Envoy Medical Stock Down 1.9 %
COCH opened at $3.11 on Tuesday. Envoy Medical has a twelve month low of $0.75 and a twelve month high of $11.72. The company has a fifty day simple moving average of $2.49 and a 200 day simple moving average of $3.48.
Envoy Medical (NASDAQ:COCH – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.03). The company had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.08 million. Equities research analysts forecast that Envoy Medical will post -1.36 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Envoy Medical
About Envoy Medical
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
Further Reading
- Five stocks we like better than Envoy Medical
- There Are Different Types of Stock To Invest In
- Emerging Markets: What They Are and Why They Matter
- Ride Out The Recession With These Dividend KingsĀ
- Recession or Not, These 3 Stocks Are Winners
- Which Wall Street Analysts are the Most Accurate?
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.